Logo

American Heart Association

  18
  0


Final ID: Sa4019

Evaluating the Outcomes and Complications of Implantable Cardioverter Defibrillator Therapy in Hypertrophic Cardiomyopathy

Abstract Body (Do not enter title and authors here):
Background: Implantable cardioverter-defibrillators (ICDs) are critical for preventing sudden cardiac death in patients with hypertrophic cardiomyopathy (HCM). However, ICD implantation is associated with risks, including inappropriate therapy, lead failure, and pocket bleeding, which may impact patient outcomes.
Research Question: What are the incidence rates of complications and outcomes associated with ICD implantation in HCM patients?
Objective: To quantify the annualized incidence rates of ICD-related complications and clinical outcomes, including appropriate interventions, inappropriate therapy, mortality, and device-related adverse events, in HCM patients.
Methods: This PRISMA-compliant systematic review and meta-analysis included 30 studies from PubMed and ScienceDirect, reporting outcomes and complications post-ICD implantation in HCM patients. Data on ICD interventions, mortality, and device-related complications were extracted. Pooled annualized incidence rates were calculated using random- and fixed-effects models.
Results: The meta-analysis included 5,618 HCM patients with ICDs. The annualized rate of appropriate ICD interventions was 4.00%. All-cause mortality was 1.30% per year, with cardiac and non-cardiac mortality each at 0.60% per year. Inappropriate therapy occurred at 3.80% per year. Device-related complications included lead malfunction (1.40%), lead displacement (1.10%), infection (0.70%), pocket bleeding (0.60%), cardiac tamponade (0.20%), deep vein thrombosis (0.30%), and pneumothorax (0.10%) per year. Heart transplant occurred at 0.80% per year.
Conclusions: ICDs in HCM patients demonstrate a favorable annualized appropriate intervention rate of 4.00% and low mortality rates. However, moderate rates of inappropriate therapy and device-related complications highlight the need for careful patient selection to optimize the risk-benefit profile. Further studies are needed to refine ICD indications and reduce complications in HCM populations.
  • Khawar, Muneeb  ( King Edward Medical University , Lahore , Pakistan )
  • Ali, Shawaz  ( Midcity hospital , Lahore Pakistan , Pakistan )
  • Bajwa, Umair  ( Services Institute of Medical Sciences , Lahore , Pakistan )
  • Haider, Mobeen  ( West Virginia University , Morgantown , West Virginia , United States )
  • Aamir, Muhammad  ( Lehigh Valley Hospital Network , Macungie , Pennsylvania , United States )
  • Hadeed Khawar, Mirza Muhammad  ( Services Institute of Medical Sciences , Lahore , Pakistan )
  • Sohail, Ali  ( King Edward Medical University , Lahore , Pakistan )
  • Shaukat, Muneeba  ( King Edward Medical University , Lahore , Pakistan )
  • Khawar, Muhammad Muneeb  ( King Edward Medical University , Lahore , Pakistan )
  • Cheema, Muhammad Bilal  ( King Edward Medical University , Lahore , Pakistan )
  • Bakht, Danyal  ( King Edward Medical University , Lahore , Pakistan )
  • Bokhari, Dr. Syed Faqeer Hussain  ( King Edward Medical University , Lahore , Pakistan )
  • Shawaiz, Aliya  ( Rashid Latif Medical College , Lahore , Pakistan )
  • Author Disclosures:
    Muneeb Khawar: DO NOT have relevant financial relationships | Shawaz Ali: DO NOT have relevant financial relationships | umair bajwa: No Answer | Mobeen Haider: DO NOT have relevant financial relationships | Muhammad Aamir: No Answer | Mirza Muhammad Hadeed khawar: DO NOT have relevant financial relationships | Ali Sohail: No Answer | Muneeba Shaukat: No Answer | Muhammad Muneeb Khawar: DO NOT have relevant financial relationships | Muhammad Bilal Cheema: No Answer | Danyal Bakht: DO NOT have relevant financial relationships | Dr. Syed Faqeer Hussain Bokhari: No Answer | Shawaz ALIYA: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Cardiomyopathy, Heart Failure & Translational Therapeutics

Saturday, 11/08/2025 , 02:30PM - 03:30PM

Abstract Poster Board Session

More abstracts on this topic:
Advanced Diagnosis of Hypertrophic Cardiomyopathy with AI-ECG and Differences Based on Race and Subtype

Lewontin Myra, Perry Allison, Amos Kaitlyn, Ayers Michael, Kaplan Emily, Bilchick Kenneth, Barber Anita, Bivona Derek, Kramer Christopher, Parrish Anna, Mcclean Karen, Thomas Matthew

AI-enhanced Electrocardiographic Evaluation of Left Ventricular Ejection Fraction and Outflow Tract Gradient in Hypertrophic Cardiomyopathy

Sangha Veer, Aminorroaya Arya, Dhingra Lovedeep, Pedroso Aline, Oikonomou Evangelos, Khera Rohan

More abstracts from these authors:
Evaluating risk factors of embolism in patients with cardiac myxoma: A systematic review and meta-analysis

Qureshi Muhammad Ahmad, Hussain Muqaddas, Qureshi Ali Akram, Bakht Danyal, Ahmed Omair, Haseeb Shahan, Gupta Kartik, Baqal Omar, Hadeed Khawar Mirza Muhammad, Amir Maaz, Ali Khawar

Trends in Heart Failure and Vascular Disease Mortality Among U.S. Adults Aged 55 and Older, 1999–2019: A Retrospective Analysis

Mubarika Moosa, Aamir Muhammad, Noor Huzaifa, Zia Ul Haq Muhammad, Raza Muhammad Hassan, Safdar Ali Haseeb, Khawar Muneeb, Asghar Kanwal, Komel Aqsa, Asim Rabia

You have to be authorized to contact abstract author. Please, Login
Not Available